<DOC>
	<DOCNO>NCT02967354</DOCNO>
	<brief_summary>Cross-sectional study investigate subject different stage type 2 diabetes development expect stratification pancreatic islet mass . Non-diabetic individual assign control . The primary outcome [ 11C ] 5-hydroxy-tryptophan uptake retention pancreas surrogate marker endogenous islet mass .</brief_summary>
	<brief_title>11C5-Hydroxy-tryptophan PET Assessment Islet Mass Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Hypoglycemic Agents</mesh_term>
	<mesh_term>5-Hydroxytryptophan</mesh_term>
	<mesh_term>Tryptophan</mesh_term>
	<criteria>Type 2 diabetes fulfil criterion four different study group , healthy volunteer Ongoing pregnancy Renal failure ( GFR &lt; 60 ml/min ) Magnetic metal part body Ongoing treatment selective serotonin receptor inhibitor</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>